MeiraGTx Holdings (MGTX) Cash & Equivalents Growth (3y) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -51.77% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 24.73% |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -28.55% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 13.33% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -16.07% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 21.66% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -8.88% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 36.53% |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn | -17.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -17.05% |
| Sep 30, 2025 | -49.42% |
| Jun 30, 2025 | -23.59% |
| Mar 31, 2025 | -16.38% |
| Dec 31, 2024 | -9.03% |
| Sep 30, 2024 | -4.52% |
| Jun 30, 2024 | -16.34% |
| Mar 31, 2024 | -15.51% |
| Dec 31, 2023 | -14.57% |
| Sep 30, 2023 | -28.92% |
| Jun 30, 2023 | -21.91% |
| Mar 31, 2023 | -31.11% |
| Dec 31, 2022 | -20.19% |
| Sep 30, 2022 | -23.22% |
| Jun 30, 2022 | -29.34% |
| Mar 31, 2022 | -20.61% |
| Dec 31, 2021 | 26.39% |
| Sep 30, 2021 | 17.44% |
| Jun 30, 2021 | 19.08% |
| Mar 31, 2021 | 83.11% |
| Dec 31, 2020 | 189.09% |
| Sep 30, 2020 | 221.00% |
| Jun 30, 2020 | 231.85% |